The Comparability of Lipid-based and Body Mass Index-based Cardiovascular Disease Risk Scores: Using the Rwanda

Jean Berchmans Niyibizi1, Kufre Joseph Okop2, Naomi Levitt2

  • 1Single Project Implementation Unit, University of Rwanda, Kicukiro, Kigali, Rwanda.

Insights

Body mass index (BMI)-based cardiovascular disease (CVD) risk scores correlate well with lipid-based scores in Rwanda. BMI-based tools offer a cost-effective alternative for CVD risk assessment in resource-limited settings.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular diseases (CVDs) are a leading cause of death in Rwanda, necessitating effective risk assessment tools.
  • Cardiovascular disease risk score tools are recommended for identifying high-risk individuals for timely management.

Purpose of the Study:

  • To evaluate the comparability of body mass index (BMI)-based and lipid-based cardiovascular disease (CVD) risk scores within the Rwandan population.
  • To determine the utility of BMI-based risk scores as a cost-effective alternative in resource-limited settings.

Main Methods:

  • Secondary analysis of 4185 participants from the 2012-2013 Rwanda non-communicable diseases risk factors survey.
  • Calculation of individual CVD risk scores using both BMI-based and lipid-based algorithms.
  • Statistical comparison using Spearman rank correlation and Cohen's Kappa coefficients.

Main Results:

  • A significant positive correlation was observed between BMI-based and lipid-based algorithms for 10-year CVD risk prediction (Spearman's rho > 0.90, p<0.001).
  • Moderate agreement was found between the two methods for CVD risk characterization (Kappa = 0.52 for overall/men, Kappa = 0.48 for women, p<0.001).

Conclusions:

  • BMI-based CVD risk algorithms demonstrate strong correlation and moderate agreement with lipid-based methods in Rwanda.
  • The BMI-based algorithm presents a viable, cost-effective alternative for CVD risk assessment in resource-limited healthcare environments.
Abstract

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
351
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
178
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
297
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
470
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
878
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
622